Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Search Results
FilterYour Filters
Language : danish Language : english Language : hausa Language : mandarin chinese Language : slovak, spanish, latvian, slovenian, danish, french, finnish, hungarian, dutch, english, maltese, portuguese, greek, lithuanian, czech, polish, italian, romanian, german, swedish, bulgarian, estonian Language : yupik Publisher : ultragenyx pharmaceutical inc Format : Reports Filter by : Subject Reset filters
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
-
Source:
A Phase 2 Open-label Study to Evaluate the Safety of Aceneuramic Acid Extended Release (Ace-ER) Tablets in GNE Myopathy (GNEM) (Also Known as Hereditary Inclusion Body
Record details
-
Source:
A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Single and Repeat Doses of Sialic Acid Extended Release (SA-ER) Tables in Patients With Hereditary
Record details
-
Source:
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Dose and Pharmacodynamic Efficacy of Sialic Acid-Extended Release (SA-ER) Tablets in Patients With GNE
Record details
-
Source:
GNE-Myopathy Disease Monitoring Program (GNEM-DMP): A Registry and Prospective Observational Natural History Study to Assess GNE Myopathy or Hereditary Inclusion Body
Record details
-
Source:
An Open-label Phase 2 Extension Study to Evaluate the Long Term Safety and Efficacy of Sialic Acid-Extended Release (SA-ER) Tablets and Sialic Acid-Immediate Release (SA-IR) Capsules in Patients With
Record details
-
Source:
Phase 3B Open-Label Extension Study to Evaluate the Safety and Efficacy of Aceneuramic Acid Extended-Release (Ace-ER) Tablets in Patients With GNE Myopathy (GNEM) or Hereditary
Record details
-
Source:
Lochmuller H, Behin A, Caraco Y, Lau H, Mirabella M, Tournev I, Tarnopolsky M, Pogoryelova O, Woods C, Lai A, Shah J, Koutsoukos T, Skrinar A, Mansbach H, Kakkis E, Mozaffar T. A phase 3 randomized
Record details
_0.png)
